Top Midday Decliners

MT Newswires Live01-08 02:45

Amesite (AMST) said Tuesday that it priced an underwritten public offering of more than 1.2 million shares at $3 apiece, targeting gross proceeds of about $3.6 million.

Shares slumped 34% following a jump in intraday trading volume to over 770,000 from a daily average of about 47,000.

Lifeward (LFWD) said Tuesday it signed a definitive agreement to issue and sell about 1.82 million ordinary shares at $2.75 apiece, targeting $5 million in gross proceeds in a registered direct offering.

Shares retreated 25% as intraday trading volume climbed to more than 3.09 million from a daily average of roughly 149,000.

Olema Pharmaceuticals (OLMA) disclosed late Monday plans for two prospective securities offerings, including up to $200 million of its common or preferred stock and warrants to buy either shares or debt securities.

Shares slipped 3.4%, with intraday trading volume at over 1.5 million versus the stock's daily average of about 758,000.

Price: 2.66, Change: -1.39, Percent Change: -34.32

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2501736380?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-08 02:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2501736380","market":"hk","top_or_hot":-1,"title":"Top Midday Decliners","media":"MT Newswires Live","content":"<html><body><p> Amesite (AMST) said Tuesday that it priced an underwritten public offering of more than 1.2 million shares at $3 apiece, targeting gross proceeds of about $3.6 million.</p><p>Shares slumped 34% following a jump in intraday trading volume to over 770,000 from a daily average of about 47,000.</p><p>Lifeward (LFWD) said Tuesday it signed a definitive agreement to issue and sell about 1.82 million ordinary shares at $2.75 apiece, targeting $5 million in gross proceeds in a registered direct offering.</p><p>Shares retreated 25% as intraday trading volume climbed to more than 3.09 million from a daily average of roughly 149,000.</p><p>Olema Pharmaceuticals (OLMA) disclosed late Monday plans for two prospective securities offerings, including up to $200 million of its common or preferred stock and warrants to buy either shares or debt securities.</p><p>Shares slipped 3.4%, with intraday trading volume at over 1.5 million versus the stock's daily average of about 758,000.</p><p>Price: 2.66, Change: -1.39, Percent Change: -34.32</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Decliners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Decliners\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-01-08 02:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Amesite (AMST) said Tuesday that it priced an underwritten public offering of more than 1.2 million shares at $3 apiece, targeting gross proceeds of about $3.6 million.Shares slumped 34% following a ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2501736380","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2501736380","pubTimestamp":1736275502,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Amesite  said Tuesday that it priced an underwritten public offering of more than 1.2 million shares at $3 apiece, targeting gross proceeds of about $3.6 million.Shares slumped 34% following a jump in intraday trading volume to over 770,000 from a daily average of about 47,000.Lifeward  said Tuesday it signed a definitive agreement to issue and sell about 1.82 million ordinary shares at $2.75 apiece, targeting $5 million in gross proceeds in a registered direct offering.Shares retreated 25% as intraday trading volume climbed to more than 3.09 million from a daily average of roughly 149,000.Olema Pharmaceuticals  disclosed late Monday plans for two prospective securities offerings, including up to $200 million of its common or preferred stock and warrants to buy either shares or debt securities.Shares slipped 3.4%, with intraday trading volume at over 1.5 million versus the stock's daily average of about 758,000.Price: 2.66, Change: -1.39, Percent Change: -34.32","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BK4505":"高瓴资本持仓","BK4082":"医疗保健设备","AMST":"Amesite Inc.","OLMA":"Olema Pharmaceuticals, Inc.","BK4204":"教育服务","LFWD":"Lifeward Ltd"},"translate_title":"午盘跌幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMST":0.9,"LFWD":0.9,"OLMA":0.9},"content_text":"Amesite (AMST) said Tuesday that it priced an underwritten public offering of more than 1.2 million shares at $3 apiece, targeting gross proceeds of about $3.6 million.Shares slumped 34% following a jump in intraday trading volume to over 770,000 from a daily average of about 47,000.Lifeward (LFWD) said Tuesday it signed a definitive agreement to issue and sell about 1.82 million ordinary shares at $2.75 apiece, targeting $5 million in gross proceeds in a registered direct offering.Shares retreated 25% as intraday trading volume climbed to more than 3.09 million from a daily average of roughly 149,000.Olema Pharmaceuticals (OLMA) disclosed late Monday plans for two prospective securities offerings, including up to $200 million of its common or preferred stock and warrants to buy either shares or debt securities.Shares slipped 3.4%, with intraday trading volume at over 1.5 million versus the stock's daily average of about 758,000.Price: 2.66, Change: -1.39, Percent Change: -34.32","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2501736380"}